Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The ...

Use of HMME-PDT showed greater improvement in PWS lesion clearance than PDL, but was associated with more hyperpigmentation and scarring.

Study focuses on advanced gastrointestinal cancer patients. Kyoto University has partnered with BostonGene on a multicentre ...

Photodynamic therapy (PDT) — a treatment most commonly thought of for field cancerization — is an effective tool for reducing rhytides and lentigines, results from a small prospective study showed.

Photodynamic therapy (PDT) constitutes a minimally invasive modality for cancer treatment that relies on photoactivation of a light‐sensitive agent, yielding reactive oxygen species (ROS) that inflict ...

The photodynamic therapy market is poised for growth driven by its minimally invasive and targeted approach, extended from ...

An international team led by physics researchers at The University of Texas at Arlington has published a paper in Bioactive Materials that describes a breakthrough method of photodynamic therapy (PDT) ...

Prognostic factors in elderly patients with grade 3 gliomas. Background: Usual treatment of brain tumors includes surgery, radiotherapy and chemotherapy, but the general prognosis is bad, with local ...

Photodynamic therapy (PDT) can lead to development of antigen-specific immune response and PDT-mediated immunity can be potentiated by T regulatory cell (Treg) depletion. We investigated whether the ...

A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a ...

Photodynamic therapy, or using light to inactivate viruses, bacteria, and other microbes, has garnered promising results in recent decades for treating respiratory tract infections and some types of ...

The 19th World Congress of the International Federation for Cervical Pathology and Colposcopy (IFCPC) took place in Paris, France, in 2026.